Drug Pipeline

AUTO1 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
7
Active Studies
6
Recruiting
3
Top Sponsors
Active Studies by Phase
Phase 2
3
Phase 1/2
1
Phase 1
3
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07053800 Obe-cel in Severe, Refractory Systemic Lupus Erythematosus With Active Lupus Nephritis Lupus Nephritis Recruiting
NCT07053059 Phase 2 Study Assessing the Clinical Activity and Safety of Obecabtagene Autoleucel as a… Acute Lymphocytic Leukemia (ALL) Recruiting
NCT07400029 A Study of Obecabtagene Autoleucel in People With B-cell Acute Lymphoblastic Leukemia Acute Lymphoblastic Leukemia Recruiting
Phase 1/2
NCT04404660 A Study of CD19 Targeted CAR T Cell Therapy in Adult Patients With Relapsed or Refractory… Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia Active, Not Recruiting
Phase 1
NCT06333483 Obe-cel in Adolescent [Applicable in UK Only] and Adult Severe, Refractory Systemic Lupus… Systemic Lupus Erythematosus Recruiting
NCT06173518 A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or… Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia Recruiting
NCT07139743 Obe-cel in Refractory Progressive Forms of Multiple Sclerosis Progressive Multiple Sclerosis Recruiting
Sponsors Running AUTO1 Trials
Disease Areas
Get alerts when AUTO1 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free